Tonix Pharmaceuticals Holding (TNXP) Cash & Equivalents (2012 - 2026)
Tonix Pharmaceuticals Holding's Cash & Equivalents came in at $176.23 million for Q2 2026, up 39.6% from $126.24 million a year earlier but down 5.0% from the prior quarter.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2025, Tonix Pharmaceuticals Holding's Cash & Equivalents was $207.64 million, up 108.3% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $99.68 million in FY2024 (+285.6%), $25.85 million in FY2023 (-78.5%), $120.47 million in FY2022 (-32.7%) and $178.9 million in FY2021 (+131.4%).
- The five-year range for quarterly Cash & Equivalents is $4.16 million (Q2 2024) to $207.64 million (Q4 2025).
- Year-over-year, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 226.0% over the last six quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2025 (growth of 573.2%), and the weakest in Q3 2023 (a decline of 95.1%).
- Business Quant data shows TNXP's Cash & Equivalents at $185.47 million (Q1 2026), $207.64 million (Q4 2025) and $190.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Tonix Pharmaceuticals Holding | 149.62 Mn | 149.62 Mn | 12.84 Mn | 176.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 176.23 Mn |
| Mar 31, 2026 | 185.47 Mn |
| Dec 31, 2025 | 207.64 Mn |
| Sep 30, 2025 | 190.06 Mn |
| Jun 30, 2025 | 126.24 Mn |
| Mar 31, 2025 | 131.72 Mn |
| Dec 31, 2024 | 99.68 Mn |
| Sep 30, 2024 | 28.23 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Mar 31, 2024 | 7.05 Mn |
| Dec 31, 2023 | 25.85 Mn |
| Sep 30, 2023 | 6.91 Mn |
| Jun 30, 2023 | 25.62 Mn |
| Mar 31, 2023 | 71.98 Mn |
| Dec 31, 2022 | 120.47 Mn |
| Sep 30, 2022 | 139.98 Mn |
| Jun 30, 2022 | 145.48 Mn |
| Mar 31, 2022 | 140.44 Mn |
| Dec 31, 2021 | 178.90 Mn |
| Sep 30, 2021 | 182.97 Mn |
API Access
Tonix Pharmaceuticals Holding Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TNXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TNXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TNXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();